US Stock MarketDetailed Quotes

ADXS Ayala Pharmaceuticals

Watchlist

0.550000
+0.010000+1.85%

15min DelayClose Apr 25 16:00 ET

23.45MMarket Cap-219P/E (TTM)

Ayala Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Total revenue

-98.12%13K

-76.32%9K

-80.26%692K

105K

-85.44%91K

-95.01%38K

-52.98%458K

-5.45%3.51M

Operating revenue

-98.12%13K

--0

-76.32%9K

-80.26%692K

--105K

-85.44%91K

-95.01%38K

-52.98%458K

-5.45%3.51M

Cost of revenue

-97.84%13K

-76.32%9K

-82.83%602K

105K

-85.44%91K

-95.01%38K

-62.22%368K

-5.45%3.51M

Gross profit

90K

Operating expense

-3.53%36.27M

-9.72%8.78M

-29.26%7.13M

8.07%8.49M

-4.14%37.59M

9.73M

5.37%10.08M

-26.32%7.85M

7.76%9.94M

31.71%39.22M

Selling and administrative expenses

25.08%12.19M

56.31%3.37M

-49.74%1.45M

21.61%2.76M

5.01%9.74M

--2.16M

31.07%2.88M

-10.41%2.27M

5.99%2.44M

25.86%9.28M

-General and administrative expense

25.08%12.19M

56.31%3.37M

-49.74%1.45M

21.61%2.76M

5.01%9.74M

--2.16M

31.07%2.88M

-10.41%2.27M

5.99%2.44M

25.86%9.28M

Research and development costs

-13.54%24.08M

-28.52%5.41M

-21.06%5.68M

2.56%5.72M

-6.98%27.85M

--7.57M

-2.29%7.2M

-31.29%5.58M

8.35%7.5M

33.63%29.94M

Operating profit

3.30%-36.27M

9.72%-8.78M

29.26%-7.13M

-8.07%-8.49M

4.37%-37.5M

-9.73M

-5.37%-10.08M

26.32%-7.85M

-6.78%-9.85M

-31.71%-39.22M

Net non-operating interest income expense

-21,340.54%-15.72M

-47,948.48%-15.79M

-14,400.00%-143K

-104.76%-86K

128.46%74K

33K

101.59%1K

-90.91%-42K

117.39%16K

-564.29%-260K

Non-operating interest income

-62.16%28K

----

--74K

----

Non-operating interest expense

--15.75M

----

104.76%86K

--0

----

90.91%42K

----

--260K

Total other finance cost

----

14,400.00%143K

----

-101.59%-1K

----

-117.39%-16K

----

Other net income (expense)

Income before tax

-38.89%-51.98M

-153.51%-24.57M

27.83%-7.27M

-8.59%-8.57M

5.19%-37.43M

-9.69M

-4.67%-10.08M

26.08%-7.89M

-5.56%-9.84M

-32.83%-39.48M

Income tax

-769.86%-3.91M

37.33%103K

-38.68%65K

-40.65%127K

-24.74%584K

75K

-36.53%106K

32.10%214K

-23.79%189K

82.59%776K

Net income

-26.46%-48.07M

-152.62%-24.67M

27.94%-7.34M

-7.29%-8.7M

5.57%-38.01M

-9.77M

-3.97%-10.19M

25.21%-8.11M

-4.80%-10.03M

-33.53%-40.25M

Net income continuous Operations

-26.46%-48.07M

-152.62%-24.67M

27.94%-7.34M

-7.29%-8.7M

5.57%-38.01M

---9.77M

-3.97%-10.19M

25.21%-8.11M

-4.80%-10.03M

-33.53%-40.25M

Minority interest income

Net income attributable to the parent company

-26.46%-48.07M

-152.62%-24.67M

27.94%-7.34M

-7.29%-8.7M

5.57%-38.01M

-9.77M

-3.97%-10.19M

25.21%-8.11M

-4.80%-10.03M

-33.53%-40.25M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-26.46%-48.07M

-152.62%-24.67M

27.94%-7.34M

-7.29%-8.7M

5.57%-38.01M

-9.77M

-3.97%-10.19M

25.21%-8.11M

-4.80%-10.03M

-33.53%-40.25M

Basic earnings per share

39.15%-7.99

37.32%-2.0808

56.41%-1.53

35.69%-1.82

-368.93%-13.13

-3.32

-416.18%-3.51

-277.33%-2.83

10.81%-0.66

8.50%-2.8

Diluted earnings per share

39.15%-7.99

37.32%-2.0808

56.41%-1.53

35.69%-1.82

-368.93%-13.13

-3.32

-416.18%-3.51

-277.33%-2.83

10.81%-0.66

8.50%-2.8

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Total revenue	-98.12%13K	0	0	-76.32%9K	-80.26%692K	105K	-85.44%91K	-95.01%38K	-52.98%458K	-5.45%3.51M
Operating revenue	-98.12%13K	--0	--0	-76.32%9K	-80.26%692K	--105K	-85.44%91K	-95.01%38K	-52.98%458K	-5.45%3.51M
Cost of revenue	-97.84%13K	0	0	-76.32%9K	-82.83%602K	105K	-85.44%91K	-95.01%38K	-62.22%368K	-5.45%3.51M
Gross profit	0	0	0	0	90K	0	0	0	90K	0
Operating expense	-3.53%36.27M	-9.72%8.78M	-29.26%7.13M	8.07%8.49M	-4.14%37.59M	9.73M	5.37%10.08M	-26.32%7.85M	7.76%9.94M	31.71%39.22M
Selling and administrative expenses	25.08%12.19M	56.31%3.37M	-49.74%1.45M	21.61%2.76M	5.01%9.74M	--2.16M	31.07%2.88M	-10.41%2.27M	5.99%2.44M	25.86%9.28M
-General and administrative expense	25.08%12.19M	56.31%3.37M	-49.74%1.45M	21.61%2.76M	5.01%9.74M	--2.16M	31.07%2.88M	-10.41%2.27M	5.99%2.44M	25.86%9.28M
Research and development costs	-13.54%24.08M	-28.52%5.41M	-21.06%5.68M	2.56%5.72M	-6.98%27.85M	--7.57M	-2.29%7.2M	-31.29%5.58M	8.35%7.5M	33.63%29.94M
Operating profit	3.30%-36.27M	9.72%-8.78M	29.26%-7.13M	-8.07%-8.49M	4.37%-37.5M	-9.73M	-5.37%-10.08M	26.32%-7.85M	-6.78%-9.85M	-31.71%-39.22M
Net non-operating interest income expense	-21,340.54%-15.72M	-47,948.48%-15.79M	-14,400.00%-143K	-104.76%-86K	128.46%74K	33K	101.59%1K	-90.91%-42K	117.39%16K	-564.29%-260K
Non-operating interest income	-62.16%28K	----	----	----	--74K	----	----	----	----	----
Non-operating interest expense	--15.75M	----	----	104.76%86K	--0	----	----	90.91%42K	----	--260K
Total other finance cost	----	----	14,400.00%143K	----	----	----	-101.59%-1K	----	-117.39%-16K	----
Other net income (expense)
Income before tax	-38.89%-51.98M	-153.51%-24.57M	27.83%-7.27M	-8.59%-8.57M	5.19%-37.43M	-9.69M	-4.67%-10.08M	26.08%-7.89M	-5.56%-9.84M	-32.83%-39.48M
Income tax	-769.86%-3.91M	37.33%103K	-38.68%65K	-40.65%127K	-24.74%584K	75K	-36.53%106K	32.10%214K	-23.79%189K	82.59%776K
Net income	-26.46%-48.07M	-152.62%-24.67M	27.94%-7.34M	-7.29%-8.7M	5.57%-38.01M	-9.77M	-3.97%-10.19M	25.21%-8.11M	-4.80%-10.03M	-33.53%-40.25M
Net income continuous Operations	-26.46%-48.07M	-152.62%-24.67M	27.94%-7.34M	-7.29%-8.7M	5.57%-38.01M	---9.77M	-3.97%-10.19M	25.21%-8.11M	-4.80%-10.03M	-33.53%-40.25M
Minority interest income
Net income attributable to the parent company	-26.46%-48.07M	-152.62%-24.67M	27.94%-7.34M	-7.29%-8.7M	5.57%-38.01M	-9.77M	-3.97%-10.19M	25.21%-8.11M	-4.80%-10.03M	-33.53%-40.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-26.46%-48.07M	-152.62%-24.67M	27.94%-7.34M	-7.29%-8.7M	5.57%-38.01M	-9.77M	-3.97%-10.19M	25.21%-8.11M	-4.80%-10.03M	-33.53%-40.25M
Basic earnings per share	39.15%-7.99	37.32%-2.0808	56.41%-1.53	35.69%-1.82	-368.93%-13.13	-3.32	-416.18%-3.51	-277.33%-2.83	10.81%-0.66	8.50%-2.8
Diluted earnings per share	39.15%-7.99	37.32%-2.0808	56.41%-1.53	35.69%-1.82	-368.93%-13.13	-3.32	-416.18%-3.51	-277.33%-2.83	10.81%-0.66	8.50%-2.8
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall